Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinlian Gout Granule is a Traditional Chinese Medicine (TCM) hospital preparation developed by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, affiliated with the Shanghai University of Traditional Chinese Medicine. It is specifically formulated for the treatment of gouty arthritis, particularly during the remission phase to prevent recurrence. The formulation is based on TCM principles of clearing heat, detoxifying, and resolving dampness. In clinical practice, it is often utilized as part of a staged integrative treatment regimen, where it follows acute-phase interventions. Its pharmacological profile likely involves the modulation of inflammatory cytokines and the maintenance of stable uric acid levels, although as a complex herbal mixture, its exact molecular mechanisms are multi-targeted.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinlian Gout Granule.